Tyme technologies news4/20/2023 ![]() ![]() (NASDAQ:TYME), today announced that the companies have entered into a definitive merger agreement pursuant to which Syros will acquire TYME, including its pipeline assets and net cash at closing which after accounting for wind-down and transaction expenses is currently estimated to be approximately $60 & BEDMINSTER, N.J., July 05, 2022-Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and TYME Technologies, Inc. ![]() Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private PlacementĬAMBRIDGE, Mass. The combined company will be led by Syros' existing management team, inc TYME stockholders are expected to receive approximately 0.4312 shares of Syros shares for each share of TYME share. Syros expects to issue approximately 74.3 million shares. Syros Pharmaceuticals Inc (NASDAQ: SYRS) has agreed to acquire TYME Technologies Inc (NASDAQ: TYME), including its pipeline assets and net cash, after accounting for wind-down and transaction expenses currently estimated to be approximately $60 million. TYME Technologies Shares Surge On Merger Agreement With Syros Pharma Syros Pharmaceuticals is set to acquire a New Jersey biotech firm called Tyme Technologies Inc., extending its cash runway into 2025 at a time when biotech stocks are being hammered. Syros to acquire New Jersey biotech Tyme Technologies Mergers and acquisitions are starting to ramp up in Massachusetts' life sciences sector, but analysts believe the biggest buys are still yet to come. M&A activity picks up among life sciences firms (“Syros”) and “FOR” all other matters to be voted upon at the Company’s upcoming Special Meeting of Stockholders (the (“ISS”) have recommended that Tyme stockholders vote “FOR” the previously announced merger of Tyme and Syros Pharmaceuticals, Inc. (“Glass Lewis”) and Institutional Shareholder Services Inc. (NASDAQ:TYME) (“Tyme” or the “Company”), today announced that independent proxy advisory firms Glass, Lewis & Co. 07, 2022 (GLOBE NEWSWIRE) - Tyme Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS Recommend Stockholders Vote “FOR” Proposed Merger of Syros and TymeīEDMINSTER, N.J., Sept. (NASDAQ:TYME) today announced the results of the special meetings of the stockholders of Syros and TYME, respectively, each held on September 15, 20 (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and Tyme Technologies, Inc. 15, 2022 (GLOBE NEWSWIRE) - Syros Pharmaceuticals, Inc. Combined Company to Trade on Nasdaq Under Ticker “SYRS” - Syros Announces 1-for-10 Reverse Stock Split of Common Stock - CAMBRIDGE, Mass. Syros and Tyme Technologies Announce Stockholder Approval of Merger William White on InvestorPlace | September 16, 2022 We're starting off the final trading day of the week with a look at the biggest pre-market stock movers for Friday and what's moving them! Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |